A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC

Clinical trial NCT07255664 · RECRUITING

Trial details

NCT number: NCT07255664
Sponsor: CuraCell TX AB
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer Prostate Cancer Metastatic Prostate Cancer Locally Advanced

Start date: 2025-11-13
Primary completion: 2027-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.